Tapewire

OTC · USD

BCLI

BRAINSTORM CELL THERAPEUTICS INC.

Export transactions ↓
Tapewire entity
7869
SEC CIK
0001137883
Parsed reports
149

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 24, 2026 Filed Jul 28, 2026 21:01 UTC GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-087588 · tm2621485-2_4seq1.xml · nonDerivative · entry 1

FRENKEL JACOB A · CIK 0001237418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,777

F1 · shares: Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date.

Read SEC document
July 24, 2026 Filed Jul 28, 2026 21:00 UTC
Pitts Peter JoeDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 900,000 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001104659-26-087584 · tm2621485-1_4seq1.xml · derivative · entry 1

Pitts Peter Joe · CIK 0002138486 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Stock · 900,000 shares

Expires 2036-07-24

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:07 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.70 Strike: $0.70 $105,000.00
Disclosure

SEC source: 0001104659-26-064658 · tm267728-6_4seq1.xml · derivative · entry 1

Bairu Menghisteab · CIK 0001891933 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:06 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.70 Strike: $0.70 $105,000.00
Disclosure

SEC source: 0001104659-26-064657 · tm267728-5_4seq1.xml · derivative · entry 1

Polverino Anthony J. · CIK 0001729957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:05 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.70 Strike: $0.70 $157,500.00
Disclosure

SEC source: 0001104659-26-064656 · tm267728-4_4seq1.xml · derivative · entry 1

HARTOUNIAN HARTOUN · CIK 0001214476 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:03 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.70 Strike: $0.70 $105,000.00
Disclosure

SEC source: 0001104659-26-064653 · tm267728-3_4seq1.xml · derivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:02 UTC
Naor NirDirector
GrantStock Option (Right to Buy) · Derivative 180,000 $0.70 Strike: $0.70 $126,000.00
Disclosure

SEC source: 0001104659-26-064652 · tm267728-2_4seq1.xml · derivative · entry 1

Naor Nir · CIK 0001982278 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 20, 2026 22:00 UTC GrantStock Option (Right to Buy) · Derivative 225,000 $0.70 Strike: $0.70 $157,500.00
Disclosure

SEC source: 0001104659-26-064650 · tm267728-1_4seq1.xml · derivative · entry 1

Dagher Ibrahim B. · CIK 0002019599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2036-02-26

F1 · security: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F1 · price: Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.

F2 · derivative.exercise_date: The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 29, 2026 21:02 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 1,800,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068339 · tm2615354-5_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,960

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 29, 2026 21:02 UTC
Yablonka UriDirector · EVP & Chief Business Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068338 · tm2615354-4_4seq1.xml · nonDerivative · entry 1

Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,464

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 29, 2026 21:01 UTC GrantCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068336 · tm2615354-2_4seq1.xml · nonDerivative · entry 1

FRENKEL JACOB A · CIK 0001237418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,777

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 29, 2026 21:01 UTC
Patlis AllaSee Remarks
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068337 · tm2615354-3_4seq1.xml · nonDerivative · entry 1

Patlis Alla · CIK 0001639227 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,349

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
February 26, 2026 Filed May 29, 2026 21:00 UTC
ARBEL IRITDirector
GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-068335 · tm2615354-1_4seq1.xml · nonDerivative · entry 1

ARBEL IRIT · CIK 0001245607 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,054

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:36 UTC GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000894 · tm251864-9_4seq1.xml · nonDerivative · entry 1

FRENKEL JACOB A · CIK 0001237418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,777

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:36 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000895 · tm251864-10_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,960

F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:34 UTC GrantCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000893 · tm251864-8_4seq1.xml · nonDerivative · entry 1

Polverino Anthony J. · CIK 0001729957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,730

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:34 UTC
Yablonka UriDirector · EVP & Chief Business Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000892 · tm251864-7_4seq1.xml · nonDerivative · entry 2

Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,464

F3 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:34 UTC
Yablonka UriDirector · EVP & Chief Business Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000892 · tm251864-7_4seq1.xml · nonDerivative · entry 1

Yablonka Uri · CIK 0001608814 · Director · EVP & Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,464

F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan (the "Plan"). The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:33 UTC
Patlis AllaSee Remarks
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000891 · tm251864-6_4seq1.xml · nonDerivative · entry 1

Patlis Alla · CIK 0001639227 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,349

F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:32 UTC
Naor NirDirector
GrantCommon Stock 30,666 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000890 · tm251864-5_4seq1.xml · nonDerivative · entry 1

Naor Nir · CIK 0001982278 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,465

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:32 UTC GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000889 · tm251864-4_4seq1.xml · nonDerivative · entry 1

Lindborg Stacy · CIK 0001813667 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,229

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:31 UTC
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000888 · tm251864-3_4seq1.xml · nonDerivative · entry 1

HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,000

F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:31 UTC GrantCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000887 · tm251864-2_4seq1.xml · nonDerivative · entry 1

Bairu Menghisteab · CIK 0001891933 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Stock Incentive Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 22:30 UTC
ARBEL IRITDirector
GrantCommon Stock 30,666 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-000885 · tm251864-1_4seq1.xml · nonDerivative · entry 1

ARBEL IRIT · CIK 0001245607 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,054

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
January 01, 2025 Filed Jan 7, 2025 21:11 UTC
Dagher Ibrahim B.Chief Medical Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-001674 · tm251864-11_4seq1.xml · nonDerivative · entry 1

Dagher Ibrahim B. · CIK 0002019599 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,849

F1 · shares: Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 12:00 UTC
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 1,836 $3.43 $6,292.34
Disclosure

SEC source: 0001104659-24-105215 · tm2425378-1_4seq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,960

F2 · shares: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

F2 · price: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.40 to $3.45, inclusive.

F2 · balance_after: Reflects the Issuer's 1-for-15 reverse stock split effected market open on October 1, 2024.

Read SEC document
September 30, 2024 Filed Oct 2, 2024 12:00 UTC
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 22,000 $0.23 $5,016.00
Disclosure

SEC source: 0001104659-24-105215 · tm2425378-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,186,865

F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.2258 to $0.2302, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

Read SEC document
July 19, 2024 Filed Jul 24, 2024 20:05 UTC
Dagher Ibrahim B.Chief Medical Officer
SaleCommon Stock 63,000 $0.35 $22,068.90
Disclosure

SEC source: 0001104659-24-082328 · tm2420104-1_4seq1.xml · nonDerivative · entry 1

Dagher Ibrahim B. · CIK 0002019599 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.3455 to $0.366, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
June 24, 2024 Filed Jun 26, 2024 01:04 UTC
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001104659-24-074873 · tm2418256-2_4seq1.xml · derivative · entry 2

HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-06-24

F2 · derivative.exercise_date: The option (the "Option"), awarded under the Plan, shall vest and become exercisable as to 25% of the underlying shares on June 24, 2025, and the remaining shares underlying the Option shall vest and become exercisable in equal quarterly installments thereafter, until fully vested and exercisable on the fourth anniversary of the grant date, provided that the Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date.

Read SEC document
June 24, 2024 Filed Jun 26, 2024 01:04 UTC
HARTOUNIAN HARTOUNEVP, Chief Operating Officer
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-074873 · tm2418256-2_4seq1.xml · nonDerivative · entry 1

HARTOUNIAN HARTOUN · CIK 0001214476 · EVP, Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: Represents shares of restricted stock units ("RSUs") awarded under the Issuer's 2014 Stock Incentive Plan (the "Plan"). The RSUs will vest in full on June 24, 2025, provided that the Reporting Person remains employed by Issuer from the date of grant through the vesting date.

Read SEC document
May 28, 2024 Filed Jun 3, 2024 13:00 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 15,000 $0.52 $7,774.50
Disclosure

SEC source: 0001104659-24-067529 · tm2416255-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,164,865

F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 28, 2024 Filed Jul 31, 2024 20:09 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 15,000 $0.52 $7,774.50
Disclosure

SEC source: 0001104659-24-084344 · tm2420560-7_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,164,865

F1 · kind: On June 3, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
May 22, 2024 Filed May 23, 2024 10:00 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 25,000 $0.64 $16,000.00
Disclosure

SEC source: 0001104659-24-064415 · tm2415334-1_4seq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149,865

Read SEC document
May 22, 2024 Filed Jul 31, 2024 20:08 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 25,000 $0.64 $16,000.00
Disclosure

SEC source: 0001104659-24-084343 · tm2420560-6_4aseq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149,865

F1 · kind: On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
May 21, 2024 Filed May 23, 2024 10:00 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 25,000 $0.58 $14,475.00
Disclosure

SEC source: 0001104659-24-064415 · tm2415334-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,124,865

Read SEC document
May 21, 2024 Filed Jul 31, 2024 20:08 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 25,000 $0.58 $14,475.00
Disclosure

SEC source: 0001104659-24-084343 · tm2420560-6_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,124,865

F1 · kind: On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
May 13, 2024 Filed May 14, 2024 11:53 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 10,000 $0.49 $4,900.00
Disclosure

SEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 3

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,099,865

Read SEC document
May 13, 2024 Filed Jul 31, 2024 20:07 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 10,000 $0.49 $4,900.00
Disclosure

SEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 3

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,099,865

F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
May 11, 2024 Filed May 14, 2024 11:53 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 10,000 $0.47 $4,665.00
Disclosure

SEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,089,865

Read SEC document
May 11, 2024 Filed Jul 31, 2024 20:07 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 10,000 $0.47 $4,665.00
Disclosure

SEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,089,865

F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
May 10, 2024 Filed May 14, 2024 11:53 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 20,000 $0.47 $9,300.00
Disclosure

SEC source: 0001104659-24-060889 · tm2414376-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,079,865

Read SEC document
May 10, 2024 Filed Jul 31, 2024 20:07 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 20,000 $0.47 $9,300.00
Disclosure

SEC source: 0001104659-24-084341 · tm2420560-5_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,079,865

F1 · kind: On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
May 07, 2024 Filed May 7, 2024 23:41 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 66,300 $0.37 $24,816.09
Disclosure

SEC source: 0001104659-24-058218 · tm2413818-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,059,865

F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 07, 2024 Filed Jul 31, 2024 20:07 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 66,300 $0.37 $24,816.09
Disclosure

SEC source: 0001104659-24-084339 · tm2420560-4_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,059,865

F1 · kind: On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3738 to $0.3747, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
May 06, 2024 Filed May 7, 2024 13:14 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 135,000 $0.38 $50,665.50
Disclosure

SEC source: 0001104659-24-057784 · tm2413699-1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 993,565

F1 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
May 06, 2024 Filed Jul 31, 2024 20:06 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 135,000 $0.38 $50,665.50
Disclosure

SEC source: 0001104659-24-084337 · tm2420560-3_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 993,565

F1 · kind: On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
April 19, 2024 Filed Apr 25, 2024 20:01 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 15,000 $0.52 $7,798.50
Disclosure

SEC source: 0001104659-24-051948 · tm2412707d1_4seq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 858,565

Read SEC document
April 19, 2024 Filed Jul 31, 2024 20:06 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 15,000 $0.52 $7,798.50
Disclosure

SEC source: 0001104659-24-084336 · tm2420560-2_4aseq1.xml · nonDerivative · entry 1

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 858,565

F1 · kind: On April 25, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

Read SEC document
April 18, 2024 Filed Apr 19, 2024 10:05 UTC
Lebovits ChaimPresident & CEO
GrantCommon Stock 115,072 $0.53 $60,470.34
Disclosure

SEC source: 0001104659-24-049027 · tm2412256-1_4seq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 843,565

F2 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Read SEC document
April 18, 2024 Filed Jul 31, 2024 20:05 UTC Amendment
Lebovits ChaimPresident & CEO
PurchaseCommon Stock 115,072 $0.53 $60,470.34
Disclosure

SEC source: 0001104659-24-084334 · tm2420560-1_4aseq1.xml · nonDerivative · entry 2

Lebovits Chaim · CIK 0001406302 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 843,565

F1 · kind: On April 19, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

F3 · price: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.4936 to $0.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (3) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.